Abstract
Steady state carbamazepine (CBZ) plasma concentrations were similar in 15 epileptics receiving monotherapy and in 24 patients taking CBZ in combination with one other anticonvulsant. The ratio of CBZ 10, 11-epoxide (CBZ-E) to the parent drug was significantly higher (P less than 0.01) in those patients taking concomitant phenytoin (n = 9), phenobarbitone or primidone (n = 9), and valproic acid (n = 6) than in the patients receiving CBZ alone. In the monotherapy group, there was a significant correlation between CBZ-E/CBZ ratio and the concentration of the parent drug (P less than 0.05). If CBZ-E has equipotent anticonvulsant properties to CBZ in man as is the case in animal models, routine CBZ-E concentrations may provide further refinement in the therapeutic drug monitoring of CBZ.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet. 1978 Mar-Apr;3(2):128–143. doi: 10.2165/00003088-197803020-00003. [DOI] [PubMed] [Google Scholar]
- Bresnick E., Mukhtar H., Stoming T. A., Dansette P. M., Jerina D. M. Effect of phenobarbital and 3-methylcholanthrene administration on epoxide hydrase levels in liver microsomes. Biochem Pharmacol. 1977 May 1;26(9):891–892. doi: 10.1016/0006-2952(77)90406-3. [DOI] [PubMed] [Google Scholar]
- Eichelbaum M., Bertilsson L. Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatography. J Chromatogr. 1975 Jan 14;103(1):135–140. doi: 10.1016/s0021-9673(00)83807-8. [DOI] [PubMed] [Google Scholar]
- Eichelbaum M., Köthe K. W., Hoffman F., von Unruh G. E. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy. Clin Pharmacol Ther. 1979 Sep;26(3):366–371. doi: 10.1002/cpt1979263366. [DOI] [PubMed] [Google Scholar]
- Eichelbaum M., Köthe K. W., Hoffmann F., von Unruh G. E. Use of stable labelled carbamazepine to study its kinetics during chronic carbamazepine treatment. Eur J Clin Pharmacol. 1982;23(3):241–244. doi: 10.1007/BF00547561. [DOI] [PubMed] [Google Scholar]
- Friis M. L., Christiansen J., Hvidberg E. F. Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients. Eur J Clin Pharmacol. 1978 Nov 9;14(1):47–51. doi: 10.1007/BF00560257. [DOI] [PubMed] [Google Scholar]
- Lertratanangkoon K., Horning M. G. Metabolism of carbamazepine. Drug Metab Dispos. 1982 Jan-Feb;10(1):1–10. [PubMed] [Google Scholar]
- Levy R. H., Koch K. M. Drug interactions with valproic acid. Drugs. 1982 Dec;24(6):543–556. doi: 10.2165/00003495-198224060-00004. [DOI] [PubMed] [Google Scholar]
- MacKichan J. J., Duffner P. K., Cohen M. E. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients. Br J Clin Pharmacol. 1981 Jul;12(1):31–37. doi: 10.1111/j.1365-2125.1981.tb01851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKauge L., Tyrer J. H., Eadie M. J. Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma. Ther Drug Monit. 1981;3(1):63–70. [PubMed] [Google Scholar]
- Morselli P. L., Baruzzi A., Gerna M., Bossi L., Porta M. Carbamazepine and carbamazepine-10, 11-epoxide concentrations in human brain. Br J Clin Pharmacol. 1977 Oct;4(5):535–540. doi: 10.1111/j.1365-2125.1977.tb00782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel I. H., Wedlund P., Levy R. H. Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys. J Pharmacol Exp Ther. 1981 Jun;217(3):555–558. [PubMed] [Google Scholar]
- Pynnönen S. Pharmacokinetics of Carbamazepine in man: a review. Ther Drug Monit. 1979;1(3):409–431. doi: 10.1097/00007691-197901030-00014. [DOI] [PubMed] [Google Scholar]